Long-term therapy with agalsidase alfa for Fabry disease: safety and effects on renal function in a home infusion setting

Abstract. Background. Fabry disease is an X-linked disorder of glycosphingolipid catabolism that is the result of an intracellular deficiency in the lysosomal

Saved in:

Bibliographic Details
Main Authors:	Schiffmann, Raphael (Author) , Ries, Markus (Author) , Timmons, Margaret (Author) , Flaherty, John T. (Author) , Brady, Roscoe Owen (Author)
Format:	Article (Journal)
Language:	English
Published:	2006
In:	Nephrology, dialysis, transplantation Year: 2005, Volume: 21, Issue: 2, Pages: 345-354
ISSN:	1460-2385
DOI:	10.1093/ndt/gfi152
Online Access:	Verlag, Volltext: https://doi.org/10.1093/ndt/gfi152 Verlag, Volltext: https://academic.oup.com/ndt/article/21/2/345/1850640
Author Notes:	Raphael Schiffmann, Markus Ries, Margaret Timmons, John T. Flaherty and Roscoe O. Brady

Description
Summary:	Abstract. Background. Fabry disease is an X-linked disorder of glycosphingolipid catabolism that is the result of an intracellular deficiency in the lysosomal
Item Description:	Published: 04 October 2005 Gesehen am 16.05.2019
Physical Description:	Online Resource
ISSN:	1460-2385
DOI:	10.1093/ndt/gfi152